Acetamide → Rac-n-(3-{4-[5-(2-diethylamino-6-methyl-pyrimidin-4-yl)-[1,2,4]oxadiazol-3-yl]-2,6-dimethyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide

Participants

Reaction Steps

rac-N-(3-{4-[5-(2-Diethylamino-6-methyl-pyrimidin-4-yl)-[1,2,4]oxadiazol-3-yl]-2,6-dimethyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide is prepared in analogy to N—((S)-3-{2-ethyl-4-[5-(2-ethylamino-6-methyl-pyrimidin-4-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide using 2-diethylamino-6-methyl-pyrimidine-4-carboxylic acid and 2-hydroxy-N-{2-hydroxy-3-(N-hydroxycarbamimidoyl)-2,6-dimethyl-phenoxy]-propyl}-acetamide; LC-MS: tR=1.01 min; [M+H]+=485.30. 1H NMR (D6-DMSO): δ 1.18 (t, J=6.8 Hz, 6H), 2.34 (s, 6H), 2.43 (s, 3H), 3.25 (m, 1H), 3.45 (m, 1H), 3.67 (q, J=6.8 Hz, 4H), 3.70-3.82 (m, 2H), 3.84 (d, J=5.5 Hz, 2H), 3.96 (m, 1H), 5.29 (d, J=5.3 Hz, 1H), 5.55 (t, J=5.5 Hz, 1H), 7.27 (s, 1H), 7.69 (t, J=5.5 Hz, 1H), 7.76 (s, 2H).

Provenance & Evidence